Navigation Links
Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO)
Date:12/6/2010

ylaxis of Hereditary Angioedema (HAE) Attacks,' Dr. Steven Villano, M.D., ViroPharma Incorporated, Exton, PA, presented open label data describing the efficacy profile of Cinryze in preventing attacks of HAE in 146 subjects with HAE.  Data from this study included the following:

  • Cinryze prophylaxis decreased the median angioedema attack rate from 3.0 to 0.2 attacks per month;
  • In subjects treated with Cinryze prophylaxis for more than one year, the degree of protection from HAE attacks was maintained over time;
  • With repeat administration of Cinryze, increases in antigenic and functional levels of C1 inhibitor (C1-INH) post therapy were maintained indicating no change in systemic exposure with repeated administration;
  • No anti-C1-INH antibodies were detected during this study.
  • No subjects were discontinued from Cinryze therapy due to an adverse event.  Headache, nausea, rash, erythema and diarrhea were the most frequently reported treatment-emergent Cinryze-related adverse events.

In a poster entitled, 'Open Label Use of Nanofiltered C1 Esterase Inhibitor (Human) (nf-C1 INH) for the Treatment of Hereditary Angioedema (HAE) Attacks,' Dr. Timothy Craig, M.D. of the Hershey Medical Center in Harrisburg, PA, described open label data describing the results of Cinryze in treating 609 attacks of HAE in 101 subjects with HAE.  Forty-three (43) subjects completed the study; most of those discontinuing the study did so because they transferred to the open label prophylaxis study or commercial Cinryze, or 3-month follow up was no longer required.  Data from the study included the following:

  • Unequivocal relief, defined as the presence of three consecutive 15 minute assessments consistent with improvement, occurred in 68 percent of attacks within one hour, and 87 percent within four hours;
  • Clinical relief, defin
    '/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. ViroPharma Receives Complete Response Letter for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Supplement
2. ViroPharma Announces Publication of Cinryze™ (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine
3. ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing
4. Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care
5. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
6. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
7. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
8. Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765
9. Portola Pharmaceuticals Announces Data Presentations Highlighting Syk/JAK Inhibitor Clinical Development Program at 52nd American Society of Hematology Annual Meeting
10. VIDEO from Merck and Co., Inc available on thenewsmarket.com: In Phase III Study Mercks Investigational CETP Inhibitor Anacetrapib Met Safety and Efficacy Endpoints in Patients with CHD
11. Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... BURLINGAME, Calif. , July 30, 2015 /PRNewswire/ ... Patent and Trademark Office has granted the company ... property covering Cleave,s lead molecule CB-5083. ... quinazolines as inhibitors of p97," U.S. 9,062,026, allows ... CB-5083, a first-in-class, highly selective oral inhibitor of ...
(Date:7/30/2015)... , July 30, 2015  Alimera Sciences, Inc. (NASDAQ: ... in the research, development and commercialization of prescription ophthalmic ... quarter fiscal year 2015 financial results after the market ... call will follow on the same day at 4:30 ... President and Chief Executive Officer, and Rick Eiswirth ...
(Date:7/30/2015)...   HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the ... revenue of $73.6 million for the quarter ended ... the quarter ended June 30, 2014.  Currency fluctuations ... nine percentage points, during the three months ended ...
Breaking Medicine Technology:Alimera Sciences To Release Second Quarter Fiscal Year 2015 Financial Results 2HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 2HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 3HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 4HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 5HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 6HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 7HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 8HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 9HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 10HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 11HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 12HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 13HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 14
... , , NEW YORK, ... customizable webcasting and streaming media solutions and services, will ... Midwest Chapter Event: September Education Program to a virtual ... presentation by Disney Destinations for the leading organization of ...
... , , , Timing is ... , ROSEMONT, Ill., Sept. 1 Trauma patients who sustain ... they arrive at the emergency department. A review article published in ... Academy of Orthopaedic Surgeons (JAAOS) explains that trauma patients who ...
Cached Medicine Technology:Stream57 to Webcast PCMA Midwest Chapter Meeting Live on Sept. 30th 2Trauma 411: Prolonged Surgery Should be Avoided in Certain Cases 2Trauma 411: Prolonged Surgery Should be Avoided in Certain Cases 3
(Date:7/30/2015)... ... July 30, 2015 , ... As more hospitals across the country see the ... a serious challenge. Because of growing competition, it is more important than ever ... , The team at Wound Care Advantage has found that while ...
(Date:7/30/2015)... ... ... In an effort to provide the twenty four hour continuous care desired by his ... The decision will also allow him to spend more time in the office with ... to the hospitalists at East Liverpool City Hospital.Dr. Aggarwal has always provided excellent care ...
(Date:7/30/2015)... York, NY (PRWEB) , ... July 30, 2015 ... ... Setria®Glutathione and Sustamine® L-Alanyl-L-Glutamine for people on the go. With no water needed, ... Recovery Chewable as a simple way to get the natural ingredients that may ...
(Date:7/30/2015)... ... July 30, 2015 , ... Mullin/Ashley Associates, Inc. ... three awards in the Service Industry Advertising Awards 12th annual national competition. ... Development Corporation and University of Maryland Shore Regional Health. , A Gold Award ...
(Date:7/30/2015)... ... July 30, 2015 , ... Well-known San ... the largest, family-owned low cost service and repair companies. For 35 years, they ... as growing their company to meet the demands of the changing technological environment. ...
Breaking Medicine News(10 mins):Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4Health News:River Valley Physician Dr. Aggarwal is Making Changes to his Practice 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 3Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 4Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 2Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 3Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 2Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 3
... is Pet First Aid Awareness Month and veterinary neurologist and neurosurgeon Dr. ... can help pets survive emergency situations with the right information and supplies. ... ... guide is now available from Veterinary Neuro Services to help owners ...
... TO SUPPORT ACTION ON HEALTH REFORM, INCLUDING PUBLIC PLAN ... is Malleable and Will Hinge on Actual DebateMENLO PARK, ... a majority of the public continues to say that ... or skipped health care in the past year, according ...
... The Food and Drug Administration (FDA) today announced that ... that 17-year-old girls should have unrestricted, over-the-counter access to ... & CEO of Americans United for Life said, "The ... its responsibility by not appealing the court order. The ...
... Hahnemann University Hospital is pleased to announce that the ... approval for Drexel University College of Medicine,s ... program. ABOG has granted the approval of one new ... fellowship program will further strengthen the urologic gynecology service ...
... 22, 2009 Telesso Technologies Limited, a global ... is the first site to enroll patients in ... peripheral IV catheter versus the industry,s gold standard ... the catheter clinical trial with Vascular Pathways, Inc. ...
... April 22 Turn the Corner Foundation (TTC), a leading ... education, will ring in Lyme Disease Awareness Month (LDAM) at ... 2009. The Foundation is ringing the bell a week ... of early detection of Lyme disease, carried by pinhead-sized ticks ...
Cached Medicine News:Health News:Sarasota Veterinary Neurologist Offers Free pet First aid Guide 2Health News:Six in Ten Say Family Put Off Medical Care Due to Cost 2Health News:Six in Ten Say Family Put Off Medical Care Due to Cost 3Health News:Six in Ten Say Family Put Off Medical Care Due to Cost 4Health News:Six in Ten Say Family Put Off Medical Care Due to Cost 5Health News:Six in Ten Say Family Put Off Medical Care Due to Cost 6Health News:Americans United for Life Condemns FDA Decision that Will Increase Minors' Access to Plan B 2Health News:Hahnemann University Hospital Granted Surgical Fellowship Training Program for Pelvic Floor Disorders 2Health News:Telesso initiates post-market head-to-head peripheral IV catheter study 2Health News:Turn the Corner Foundation Rings in Lyme Disease Awareness Month Early at NYSE on April 23, 2009 2Health News:Turn the Corner Foundation Rings in Lyme Disease Awareness Month Early at NYSE on April 23, 2009 3Health News:Turn the Corner Foundation Rings in Lyme Disease Awareness Month Early at NYSE on April 23, 2009 4
... CELL-DYN 3200 sets a benchmark of ... scatter for WBC, RBC, PLT and ... the needs of today's laboratory. The ... differential analysis, automated sample handling, comprehensive ...
... Point-of-Care Data Networking is hospital bedside ... data networking. In seconds, point of ... transferred from nursing stations throughout the ... instantly available to laboratory staff and ...
... QuickVue In-Line Strep A Test allows for the ... from patient throat swab specimens. , ,QuickVue In-Line ... is the first strep A test waived under ... procedure allow testing to take place at the ...
... InstaCheck® Menopause Predictor Test is an in ... FSH in urine. Changes in FSH levels ... symptoms associated with stages of menopause. The ... obtain a visual, qualitative result and is ...
Medicine Products: